About Kyle Welborn
Kyle Welborn is a director at Ascribe Bioscience.
Kyle Welborn first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Kyle Welborn in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Kyle Welborn works with at each company, as listed on that company's latest Form D.
Ascribe Bioscience Inc. · Form D, Oct 15, 2025